Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics;Pharmakokinetische/pharmakodynamische modelle für inhalationsanä sthetika

Anaesthesist

Volumn 56, Issue 6, 2007, Pages 538-556

  Kreuer, S ^a   Bruhn, J ^b   Wilhelm, W ^c   Bouillon, T ^d  

^a SAARLAND UNIVERSITY   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Klinikum St Marien Hospital   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Distribution coefficient; EEG index; Ke0 value; N2O; Opioids; Volatile anaesthetics

Indexed keywords

DESFLURANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; NITROUS OXIDE; OPIATE; SEVOFLURANE;

ANESTHESIA MECHANISM; CLINICAL PRACTICE; COMPARTMENT MODEL; DRUG BLOOD LEVEL; DRUG POTENTIATION; END TIDAL CARBON DIOXIDE TENSION; INHALATION ANESTHESIA; MATHEMATICAL MODEL; MAXIMUM ALLOWABLE CONCENTRATION; REVIEW; TISSUE DISTRIBUTION;

ALGORITHMS; ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; ELECTROENCEPHALOGRAPHY; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; NITROUS OXIDE;

EID: 34250900993     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-007-1188-7     Document Type: Review

References (126)

1. Anderson RE, Barr G, Jakobsson JG (2005) Cerebral state index during anaesthetic induction: a comparative study with propofol or nitrous oxide. Acta Anaesthesiol Scand 49: 750-753
2. Anderson RE, Jakobsson JG (2004) Entropy of EEG during anaesthetic induction: a comparative study with propofol or nitrous oxide as sole agent. Br J Anaesth 92: 167-170
3. Antognini JF, Schwartz K (1993) Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiology 79: 1244-1249
4. Antognini JF (1993) Hypothermia eliminates isoflurane requirements at 20 degrees C. Anesthesiology 78: 1152-1156
5. Bailey JM (1989) The pharmacokinetics of volatile anesthetic agent elimination: a theoretical study. J Pharmacokinet Biopharm 17: 109-123
6. Bailey JM (1997) Context-sensitive half-times and other decrement times of inhaled anesthetics. Anesth Analg 85: 681-686
7. Bialas P, Ellerkmann R, Bruhn J et al. (2005) Model-independent calculation of ke0 values. Eur J Anaesth [Suppl 34] 22: A-141
8. Bowerman B, O'Connell R (eds) (1990) Simple coefficients of determination and correlation, linear statistical models (an applied approach). PWS-KENT, Boston, pp 174-183
9. Bruhn J, Bouillon TW, Shafer SL (2001) Onset of propofol-induced burst suppression may be correctly detected as deepening of anaesthesia by approximate entropy but not by bispectral index. Br J Anaesth 87: 505-507
10. Bruhn J (2003) Vergleich verschiedener EEG-Parameter: Spektrale Eckfrequenz 95, approximate Entropie und Bispektralindex. Anaesthesiol Intensivmed 44: 17-21
11. Brunner MD, Braithwaite P, Jhaveri R et al. (1994) MAC reduction of isoflurane by sufentanil. Br J Anaesth 72: 42-46
12. Cowles AL, Borgstedt HH, Gillies AJ (1971) Tissues weights and rates of blood flow in man for the prediction of anesthetic uptake and distribution. Anesthesiology 35: 523-526
13. Cranfield KA, Bromley LM (1997) Minimum alveolar concentration of desflurane for tracheal extubation in deeply anaesthetized, unpremedicated children. Br J Anaesth 78: 370-371
14. Cromwell TH, Eger EI 2nd, Stevens WC, Dolan WM (1971) Forane uptake, excretion, and blood solubility in man. Anesthesiology 35: 401-408
15. Daniel M, Weiskopf RB, Noorani M, Eger EI 2nd (1998) Fentanyl augments the blockade of the sympathetic response to incision (MAC-BAR) produced by desflurane and isoflurane: desflurane and isoflurane MAC-BAR without and with fentanyl. Anesthesiology 88: 43-49
16. Davis NR, Mapleson WW (1981) Structure and quantification of a physiological model of the distribution of injected agents and inhaled anaesthetics. Br J Anaesth 53: 399-405
17. De Jong RH, Eger EI (1975) MAC expanded: AD50 and AD95 values of common inhalation anesthetics in man. Anesthesiology 42: 384-389
18. Dwyer R, Bennett HL, Eger EI 2nd, Heilbron D (1992) Effects of isoflurane and nitrous oxide in subanesthetic concentrations on memory and responsiveness in volunteers. Anesthesiology 77: 888-898
19. Eger EI 2nd, Bowland T, Ionescu P et al. (1997) Recovery and kinetic characteristics of desflurane and sevoflurane in volunteers after 8-h exposure, including kinetics of degradation products. Anesthesiology 87: 517-526
20. Eger EI 2nd, Gong D, Koblin DD et al. (1998) The effect of anesthetic duration on kinetic and recovery characteristics of desflurane versus sevoflurane, and on the kinetic characteristics of compound A, in volunteers. Anesth Analg 86: 414-421
21. Eger EI 2nd, Johnson BH (1987) MAC of I-653 in rats, including a test of the effect of body temperature and anesthetic duration. Anesth Analg 66: 974-976
22. Eger EI 2nd, Weiskopf RB, Eisenkraft (2002) The pharmacology of inhaled anesthetics. Br J Anaesth 56: 223-232
23. Eger EI 3rd (1987) Stability of I-653 in soda lime. Anesth Analg 66: 983-985
24. Eger EI, Lampe GH, Wauk LZ et al. (1990) Clinical pharmacology of nitrous oxide: an argument for its continued use. Anesth Analg 71: 575-585
25. Eger EI, Laster MJ, Gregory GA et al. (2003) Women appear to have the same minimum alveolar concentration as men: a retrospective study. Anesthesiology 99: 1059-1061
26. Eger EI, Saidman LJ, Brandstater B (1965) Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology 26: 756-763
27. Eger EI (2002) A brief history of the origin of minimum alveolar concentration (MAC). Anesthesiology 96: 238-239
28. Eger RR, Eger EI 2nd (1985) Effect of temperature and age on the solubility of enflurane, halothane, isoflurane, and methoxyflurane in human blood. Anesth Analg 64: 640-642
29. Ellerkmann R, Kreuer S, Roepcke H et al. (2005) A model-independent approach estimating ke0 values, describing the equilibration rate constant between plasma and effect-site concentration. Anesthesiology 103: A763
30. Ellerkmann RK, Liermann VM, Alves TM et al. (2004) Spectral entropy and bispectral index as measures of the electroencephalographic effects of sevoflurane. Anesthesiology 101: 1275-1282
31. Ellerkmann RK, Soehle M, Alves TM et al. (2006) Spectral entropy and bispectral index as measures of the electroencephalographic effects of propofol. Anesth Analg 102: 1456-1462
32. Fragen RJ, Dunn KL (1996) The minimum alveolar concentration (MAC) of sevoflurane with and without nitrous oxide in elderly versus young adults. J Clin Anesth 8: 352-356
33. Gin T, Chan MT (1994) Decreased minimum alveolar concentration of isoflurane in pregnant humans. Anesthesiology 81: 829-832
34. Glass PS, Bloom M, Kearse L et al. (1997) Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology 86: 836-847
35. Glass PS (1998) Anesthetic drug interactions: an insight into general anesthesia - its mechanism and dosing strategies. Anesthesiology 88: 5-6
36. Harris RS, Lazar O, Johansen JW, Sebel PS (2006) Interaction of propofol and sevoflurane on loss of consciousness and movement to skin incision during general anesthesia. Anesthesiology 104: 1170-1175
37. Hill AV (1910) The possible effect of the aggregration of the molecules of hemoglobin on its dissociation curves. J Physiol 40: iv-vii
38. Hornbein TF, Eger EI, Winter PM et al. (1982) The minimum alveolar concentration of nitrous oxide in man. Anesth Analg 61: 553-556
39. Hui TW, Short TG, Hong W et al. (1995) Additive interactions between propofol and ketamine when used for anesthesia induction in female patients. Anesthesiology 82: 641-648
40. Inomata S, Suwa T, Toyooka H, Suto Y (1998) End-tidal sevoflurane concentration for tracheal extubation and skin incision in children. Anesth Analg 87: 1263-1267
41. Inomata S, Yaguchi Y, Taguchi M, Toyooka H (1999) End-tidal sevoflurane concentration for tracheal extubation (MACEX) in adults: comparison with isoflurane. Br J Anaesth 82: 852-856
42. Johansen JW, Sebel PS (2000) Development and clinical application of electroencephalographic bispectrum monitoring. Anesthesiology 93: 1336-1344
43. Jones RM, Cashman JN, Eger EI 2nd et al. (1990) Kinetics and potency of desflurance (I-653) in volunteers. Anesth Analg 70: 3-7
44. Katoh T, Bito H, Sato S (2000) Influence of age on hypnotic requirement, bispectral index, and 95% spectral edge frequency associated with sedation induced by sevoflurane. Anesthesiology 92: 55-61
45. Katoh T, Ikeda K, Bito H (1997) Does nitrous oxide antagonize sevoflurane-induced hypnosis? Br J Anaesth 79: 465-468
46. Katoh T, Ikeda K (1987) The minimum alveolar concentration (MAC) of sevoflurane in humans. Anesthesiology 66: 301-303
47. Katoh T, Ikeda K (1998) The effects of fentanyl on sevoflurane requirements for loss of consciousness and skin incision. Anesthesiology 88: 18-24
48. Katoh T, Kobayashi S, Suzuki A et al. (1999) The effect of fentanyl on sevoflurane requirements for somatic and sympathetic responses to surgical incision. Anesthesiology 90: 398-405
49. Katoh T, Suguro Y, Ikeda T et al. (1993) Influence of age on awakening concentrations of sevoflurane and isoflurane. Anesth Analg 76: 348-352
50. Katoh T, Uchiyama T, Ikeda K (1994) Effect of fentanyl on awakening concentration of sevoflurane. Br J Anaesth 73: 322-325
51. Keller O, Kreuer S, Bruhn J et al. (2006) The accuracy of two pharmacokinetic data sets for propofol. Eur J Anaesth [Suppl 37] 23: A-513
52. Kennedy RR, French RA, Gilles S (2004) The effect of a model-based predictive display on the control of end-tidal sevoflurane concentrations during low-flow anesthesia. Anesth Analg 99: 1159-1163
53. Kennedy RR, French RA, Spencer C (2002) Predictive accuracy of a model of volatile anesthetic uptake. Anesth Analg 95: 1616-1621
54. Kennedy RR (2005) The effect of using different values for the effect-site equilibrium half-time on the prediction of effect-site sevoflurane concentration: a simulation study. Anesth Analg 101: 1023-1028
55. Kihara S, Yaguchi Y, Inomata S et al. (2003) Influence of nitrous oxide on minimum alveolar concentration of sevoflurane for laryngeal mask insertion in children. Anesthesiology 99: 1055-1058
56. Kissin I (2000) Depth of anesthesia and bispectral index monitoring. Anesth Analg 90: 1114-1117
57. Kreuer S, Bruhn J, Grundmann U et al. (2005) Comparison of 2 pharmacodynamic EEG models with and without a pharmacodynamic plateau. Eur J Anaesth 22 [Suppl 34]: A-100
58. Kreuer S, Wilhelm W (2006) The Narcotrend Monitor. Best Pract Res Clin Anaesthesiol 20: 111-119
59. Kreuer S, Bialas P, Bruhn J et al. (2005) Application of bispectral and narcotrend indices to the measurement of the electroencephalographic effects of desflurane. Anesthesiology 103: A820
60. Kreuer S, Biedler A, Larsen R et al. (2003) Narcotrend monitoring allows faster emergence and a reduction of drug consumption in propofol-remifentanil anesthesia. Anesthesiology 99: 34-41
61. Kreuer S, Bruhn J, Biedler A et al. (2005) Dose-response relationship between sevoflurane concentrations and Narcotrend or bispectral index. Eur J Anaesth 22 [Suppl 34]: A-119
62. Kreuer S, Bruhn J, Biedler S et al. (2006) ke0 values for propofol using different PK/PD data sets. Eur J Anaesth 23 [Suppl 37]: A-120
63. Kreuer S, Bruhn J, Buchinger H et al. (2005) Dose-response relationship between sevoflurane concentrations and Narcotrend index. Anesthesiology 103: A823
64. Kreuer S, Bruhn J, Larsen R et al. (2004) Comparison of BIS and AAI as measures of anaesthetic drug effect during desflurane-remifentanil anaesthesia. Acta Anaesthesiol Scand 48: 1168-1173
65. Kreuer S, Bruhn J, Larsen R et al. (2004) Application of Narcotrend index and bispectral index to the measurement of the EEG effects of isoflurane with and without burst suppression. Anesthesiology 101: 847-854
66. Kreuer S, Bruhn J, Larsen R et al. (2005) Pharmakodynamisches Plateau im prozessierten EEG bei Sevofluran-Anästhesien. Wissenschaftliche Arbeitstage der DGAI, Würzburg
67. Kreuer S, Wilhelm W, Grundmann U et al. (2004) Narcotrend index vs. bispectral index as EEG measures of anesthetic drug effect during propofol anesthesia. Anesth Analg 98: 692-697
68. Lang E, Kapila A, Shlugman D et al. (1996) Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology 85: 721-728
69. LeDez KM, Lerman J (1987) The minimum alveolar concentration (MAC) of isoflurane in preterm neonates. Anesthesiology 67: 301-307
70. Lerman J, Gregory GA, Eger EI 2nd (1984) Hematocrit and the solubility of volatile anesthetics in blood. Anesth Analg 63: 911-914
71. Lerman J, Schmitt-Bantel BI, Gregory GA et al. (1986) Effect of age on the solubility of volatile anesthetics in human tissues. Anesthesiology 65: 307-311
72. Lerman J, Willis MM, Gregory GA, Eger EI 2nd (1983) Osmolarity determines the solubility of anesthetics in aqueous solutions at 37 degrees C. Anesthesiology 59: 554-558
73. Lerou JG, Dirksen R, Beneken Kolmer HH et al. (1991) A system model for closed-circuit inhalation anesthesia. II. Clinical validation. Anesthesiology 75: 230-237
74. Lerou JG, Dirksen R, Beneken Kolmer HH, Booij LH (1991) A system model for closed-circuit inhalation anesthesia. I. Computer study. Anesthesiology 75: 345-355
75. Lerou JG (2004) Nomogram to estimate age-related MAC. Br J Anaesth 93: 288-291
76. Levitt DG (2002) PKQuest: volatile solutes - application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics. BMC Anesthesiology 2: 5
77. Locher S, Stadler KS, Boehlen T et al. (2004) A new closed-loop control system for isoflurane using bispectral index outperforms manual control. Anesthesiology 101: 591-602
78. Lockwood GG, Sapsed-Byrne SM, Smith MA (1997) Effect of temperature on the solubility of desflurane, sevoflurane, enflurane and halothane in blood. Br J Anaesth 79: 517-520
79. Loomis AL, Harvey EN, Hobart CA (1937) Cerebral states during sleep as studied by human brain potentials. J Exp Psychol 21: 127-144
80. Malviya S, Lerman J (1990) The blood/gas solubilities of sevoflurane, isoflurane, halothane, and serum constituent concentrations in neonates and adults. Anesthesiology 72: 793-796
81. Mapleson WW (1996) Effect of age on MAC in humans: a meta-analysis. Br J Anaesth 76: 179-185
82. Marsh B, White M, Morton N, Kenny GN (1991) Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 67: 41-48
83. McEwan AI, Smith C, Dyar O et al. (1993) Isoflurane minimum alveolar concentration reduction by fentanyl. Anesthesiology 78: 864-869
84. McKay ID, Voss LJ, Sleigh JW et al. (2006) Pharmacokinetic- pharmacodynamic modeling the hypnotic effect of sevoflurane using the spectral entropy of the electroencephalogram. Anesth Analg 102: 91-97
85. Nakajima R, Nakajima Y, Ikeda K (1993) Minimum alveolar concentration of sevoflurane in elderly patients. Br J Anaesth 70: 273-275
86. Nickalls RW, Mapleson WW (2003) Age-related iso-MAC charts for isoflurane, sevoflurane and desflurane in man. Br J Anaesth 91: 170-174
87. Olofsen E, Dahan A (1999) The dynamic relationship between end-tidal sevoflurane and isoflurane concentrations and bispectral index and spectral edge frequency of the electroencephalogram. Anesthesiology 90: 1345-1353
88. Olofsen E, Sleigh JW, Dahan A (2002) The influence of remifentanil on the dynamic relationship between sevoflurane and surrogate anesthetic effect measures derived from the EEG. Anesthesiology 96: 555-564
89. Rampil IJ, Lockhart SH, Zwass MS et al. (1991) Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. Anesthesiology 74: 429-433
90. Rampil IJ, Mason P, Singh H (1993) Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology 78: 707-712
91. Rampil IJ (1994) Anesthetic potency is not altered after hypothermic spinal cord transection in rats. Anesthesiology 80: 606-610
92. Rampil IJ (1998) A primer for electroencephalogram signal processing in anesthesia. Anesthesiology 89: 980-1002
93. Rehberg B, Bouillon T, Zinserling J, Hoeft A (1999) Comparative pharmacodynamic modeling of the electroencephalography-slowing effect of isoflurane, sevoflurane, and desflurane. Anesthesiology 91: 397-405
94. Rietbrock S, Wissing H, Kuhn I, Fuhr U (2000) Pharmacokinetics of inhaled anaesthetics in a clinical setting: description of a novel method based on routine monitoring data. Br J Anaesth 84: 437-442
95. Roizen MF, Horrigan RW, Frazer BM (1981) Anesthetic doses blocking adrenergic (stress) and cardiovascular responses to incision - MAC BAR. Anesthesiology 54: 390-398
96. Ropcke H, Konen-Bergmann M, Cuhls M et al. (2001) Propofol and remifentanil pharmacodynamic interaction during orthopedic surgical procedures as measured by effects on bispectral index. J Clin Anesth 13: 198-207
97. Ropcke H, Lier H, Hoeft A, Schwilden H (1999) Isoflurane, nitrous oxide, and fentanyl pharmacodynamic interactions in surgical patients as measured by effects on median power frequency. J Clin Anesth 11: 555-562
98. Ropcke H, Schwilden H (1996) Die Interaktion von Stickoxidul und Enfluran bei einem EEG-Median von 2-3 Hz ist additiv, aber schwacher als bei 1,0 MAC. Anaesthesist 45: 819-825
99. Ropcke H, Schwilden H (1996) Interaction of isoflurane and nitrous oxide combinations similar for median electroencephalographic frequency and clinical anesthesia. Anesthesiology 84: 782-788
100. Ropcke H, Wirz S, Bouillon T et al. (2001) Pharmacodynamic interaction of nitrous oxide with sevoflurane, desflurane, isoflurane and enflurane in surgical patients: measurements by effects on EEG median power frequency. Eur J Anaesthesiol 18: 440-449
101. Russell GB, Snider MT, Richard RB, Loomis JL (1990) Hyperbaric nitrous oxide as a sole anesthetic agent in humans. Anesth Analg 70: 289-295
102. Saidman LJ, Eger EI (1964) Effect of nitrous oxide and of narcotic premedication on the alveolar concentration of halothane required for anesthesia. Anesthesiology 25: 302-306
103. Scheller MS, Saidman LJ, Partridge BL (1988) MAC of sevoflurane in humans and the New Zealand white rabbit. Can J Anaesth 35: 153-156
104. Schmidt GN, Bischoff P, Standl T et al. (2002) Narcotrend, bispectral index, and classical electroencephalogram variables during emergence from propofol/remifentanil anesthesia. Anesth Analg 95: 1324-1330
105. Schnider TW, Minto CF, Gambus PL et al. (1998) The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 88: 1170-1182
106. Schultz B, Kreuer S, Wilhelm W et al. (2003) The Narcotrend monitor. Development and interpretation algorithms. Anaesthesist 52: 1143-1148
107. Schwilden H, Ropcke H, Drosler S (1995) Die klinische Potenz von Stickoxidul - Ist MAC der Goldstandard? Anasthesiol Intensivmed Notfallmed Schmerzther 30: 337-340
108. Schwilden H, Schüttler J, Stoeckel H (1987) Closed-loop feedback control of methohexital anesthesia by quantitative EEG analysis in humans. Anesthesiology 67: 341-347
109. Schwilden H, Stoeckel H (1987) Quantitative EEG analysis during anaesthesia with isoflurane in nitrous oxide at 1.3 and 1.5 MAC. Br J Anaesth 59: 738-745
110. Shafer SL (2004) Pharmacokinetic and pharmacodynamic analysis with NONMEM - basic concepts. Workshop, Palo Alto, California, USA, 9.17
111. Smith WD, Dutton RC, Smith NT (1996) Measuring the performance of anesthetic depth indicators. Anesthesiology 84: 38-51
112. Stevens WD, Dolan WM, Gibbons RT et al. (1975) Minimum alveolar concentrations (MAC) of isoflurande with and without nitrous oxide in patients of various ages. Anesthesiology 42: 197-200
113. Strum DP, Eger EI 2nd (1987) Partition coefficients for sevoflurane in human blood, saline, and olive oil. Anesth Analg 66: 654-656
114. Swan HD, Crawford MW, Pua HL et al. (1999) Additive contribution of nitrous oxide to sevoflurane minimum alveolar concentration for tracheal intubation in children. Anesthesiology 91: 667-671
115. Taheri S, Eger EI 2nd (1999) A demonstration of the concentration and second gas effects in humans anesthetized with nitrous oxide and desflurane. Anesth Analg 89: 774-780
116. Torri G, Damia G, Fabiani ML (1974) Effect on nitrous oxide on the anaesthetic requirement of enflurane. Br J Anaesth 46: 468-472
117. Wadhwa A, Durrani J, Sengupta P et al. (2003) Women have the same desflurane minimum alveolar concentration as men: a prospective study. Anesthesiology 99: 1062-1065
118. Westmoreland CL, Sebel PS, Gropper A (1994) Fentanyl or alfentanil decreases the minimum alveolar anesthetic concentration of isoflurane in surgical patients. Anesth Analg 78: 23-28
119. Wilhelm W, Kreuer S (2003) Das interpretierte EEG als Überwachungsverfahren in der Anästhesiologie. Anasthesiol Intensivmed 44: 8-15
120. Yasuda N, Lockhart SH, Eger EI 2nd et al. (1991) Kinetics of desflurane, isoflurane, and halothane in humans. Anesthesiology 74: 489-498
121. Yasuda N, Lockhart SH, Eger EI 2nd et al. (1991) Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg 72: 316-324
122. Yasuda N, Targ AG, Eger EI et al. (1990) Pharmacokinetics of desflurane, sevoflurane, isoflurane, and halothane in pigs. Anesth Analg 71: 340-348
123. Yasuda N, Targ AG, Eger El (1989) Solubility if I-653, sevoflurane, isoflurane, and halothane in human tissues. Anesth Analg 69: 370-373
124. Yasuda N, Weiskopf RB, Cahalan MK et al. (1991) Does desflurane modify circulatory responses to stimulation in humans? Anesth Analg. 73: 175-179
125. Zbinden AM, Maggiorini M, Petersen-Felix S et al. (1994) Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia. I. Motor reactions. Anesthesiology 80: 253-260
126. Zhou JX, Liu J (2001) The effect of temperature on solubility of volatile anesthetics in human tissues. Anesth Analg 93: 234-238